Press Releases
Lexicon Announces Sotagliflozin Data to be Presented at European Association for the Study of Diabetes
Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) today announced that data from its Phase 2 clinical study of sotagliflozin in type 1 diabetes will be presented...
Press Releases
U.S. FDA Grants Priority Review to Janssen for Daratumumab as a Treatment for Multiple Myeloma
If approved, daratumumab will offer a new option for double refractory, heavily pre-treated patients Janssen Research & Development, LLC (Janssen) announced...
Press Releases
Your Story, Your HIV Wisdom™ Brings Together HIV Voices and Supports HIV Community Organizations
Notable HIV Advocates Highlight Perspectives of People Living with or Affected by HIV to Leverage Shared Support and Self-Expression Seeking and...
Press Releases
Johnson & Johnson Announces BARDA Funding Award to Accelerate Ebola Vaccine Program
Johnson & Johnson (NYSE: JNJ) announced today that Crucell Holland B.V., one of its Janssen Pharmaceutical Companies, has been awarded $28.5 million from The...
Press Releases
Pivotal Phase II Study Showed Genentech’s Investigational Immunotherapy Atezolizumab Shrank Tumors in People with a Specific Type of Lung Cancer
Genentech will discuss results with the U.S. Food and Drug Administration (FDA) as part of atezolizumab’s Breakthrough Therapy Designation in lung cancer. ...
Press Releases
U.S. FDA Grants Breakthrough Therapy Designation for Genentech’s Investigational Medicine ACE910 for People With Hemophilia A With Factor VIII Inhibitors
First factor VIIIa-mimetic bispecific antibody to be investigated for the prophylactic treatment of hemophilia A Ninth breakthrough therapy designation for Genentech’s portfolio of medicines...
News
Pivotal Phase 3 Studies of Bezlotoxumab, Merck’s Investigational Antitoxin to Prevent Clostridium Difficile Infection Recurrence, Met Primary Endpoint
Company Plans to Submit New Drug Applications in U.S., EU and Canada in 2015 Results Presented for the First Time at...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read